Invesco Dynamic Biotechnology & Genome ETF
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company..
Debt to Assets
| Q1 2013 | 261704564 | 211.82K | 0.08% |
|---|---|---|---|
| Q2 2013 | 261704564 | 211.82K | 0.08% |
PBE Balance Sheet (Q1 2013 – Q2 2013)
| Q2 2013 | Q1 2013 | |
|---|---|---|
Assets | ||
Current assets: | ||
Cash and cash equivalents | -125.54K | -125.54K |
Short term investments | 125.54K | 125.54K |
Net receivables | 77.55K | 77.55K |
Inventory | 0 | 0 |
Other current assets | -1 | -1 |
Total current assets | 203.09K | 203.09K |
Non-current assets: | ||
Property, Plant and Equipment | 0 | 0 |
Goodwill | 0 | 0 |
Intangible assets | 0 | 0 |
Long term investments | 261.50M | 261.50M |
Other non-current assets | -261.50M | -261.50M |
Total non-current assets | 261.50M | 261.50M |
Total assets | 261.70M | 261.70M |
Liabilities | ||
| Current liabilities: | ||
Accounts payable | ||
Deferred revenue | 0 | 0 |
Short term debt | 0 | 0 |
Total current liabilities | 211.82K | 211.82K |
| Non-current liabilities: | ||
Long term debt | 0 | 0 |
Deferred tax | 0 | 0 |
Other non-current liabilities | 0 | 0 |
Total non-current liabilities | 0 | 0 |
Total liabilities | 211.82K | 211.82K |